| Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia (NCT07733037) | Peking University People's Hospital | 2026-01-10 |
| Sintilimab-Nimotuzumab Induction Followed by Chemoradiation-Nimotuzumab in LA-HNSCC: Single-Arm Phase II (NCT07310771) | Fujian Cancer Hospital | 2026-01-10 |
| Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer (NCT07410975) | Shanghai Pulmonary Hospital, Shanghai, China | 2026-01-10 |
| Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer (NCT07292207) | Nagoya City University | 2026-01-10 |
| Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer (NCT07306624) | STCube, Inc. | 2026-01-10 |
| Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and Above (NCT07354659) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2026-01-10 |
| ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults (NCT07301255) | Enveda Therapeutics | 2026-01-09 |
| A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer (NCT07335796) | Memorial Sloan Kettering Cancer Center | 2026-01-09 |
| Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma (NCT06898970) | Varun Monga, MBBS | 2026-01-09 |
| LishitonglinUS-01 Trial (NCT07769060) | Peking University First Hospital | 2026-01-09 |
| Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma (NCT07394244) | Fudan University | 2026-01-09 |
| A Study of Buntanetap in Participants With PD (NCT07284784) | Annovis Bio Inc. | 2026-01-09 |
| Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma (NCT07365280) | ZSky Biotech Inc | 2026-01-09 |
| Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients (NCT07429253) | PT. Prodia Stem Cell Indonesia | 2026-01-09 |
| A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis (NCT07321951) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-01-09 |
| PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study (NCT07335367) | Nanfang Hospital, Southern Medical University | 2026-01-09 |
| Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression (NCT07155226) | AstraZeneca | 2026-01-09 |
| Early Methylene Blue in the Microhemodynamics of Septic Patients (NCT07264543) | Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva | 2026-01-09 |
| AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) (NCT07285694) | Arsenal Biosciences, Inc. | 2026-01-09 |
| Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease (NCT07271186) | Regeneron Pharmaceuticals | 2026-01-09 |
| A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors (NCT07131202) | Suzhou Forlong Biotechnology Co., Ltd | 2026-01-08 |
| An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors (NCT07359066) | Shanghai SciBrunch Therapeutics Co., Ltd. | 2026-01-08 |
| HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors (NCT07296341) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2026-01-08 |
| Etodolac Nanogel as an Adjunct to Physiotherapy for Knee Osteoarthritis (NCT07308470) | Pharos University in Alexandria | 2026-01-08 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis (NCT07284459) | Contineum Therapeutics | 2026-01-08 |
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD (NCT07158775) | Bionic Sight LLC | 2026-01-08 |
| A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant (NCT07095452) | AbbVie | 2026-01-08 |
| Retifanlimab and Ruxolitinib In Solid Malignancies (NCT07219576) | University of California, San Diego | 2026-01-08 |
| A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis (NCT07223697) | Hoffmann-La Roche | 2026-01-08 |
| GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment (NCT07193134) | CHU de Quebec-Universite Laval | 2026-01-07 |
| Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial (NCT07218510) | City of Hope Medical Center | 2026-01-07 |
| A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors (NCT07298772) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-01-07 |
| IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer (NCT07408635) | Shanghai Pulmonary Hospital, Shanghai, China | 2026-01-07 |
| Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma (NCT06919939) | University of Miami | 2026-01-07 |
| the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer (NCT07380646) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-01-07 |
| Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy (NCT07337876) | University Hospital Tuebingen | 2026-01-07 |
| Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR (NCT07371273) | Fudan University | 2026-01-07 |
| Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above (NCT07327398) | Shanghai Institute Of Biological Products | 2026-01-07 |
| Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom (NCT07239596) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-01-06 |
| Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies (NCT07284433) | AvenCell Therapeutics, Inc. | 2026-01-06 |
| A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM (NCT07172867) | Halia Therapeutics, Inc. | 2026-01-06 |
| Iruplinalkib Tablets as Postoperative Adjuvant Therapy in Stage IA ALK-positive NSCLC With High-risk Factors (NCT07330076) | Tianjin Medical University Cancer Institute and Hospital | 2026-01-06 |
| Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1 (NCT07070999) | Gemma Biotherapeutics | 2026-01-06 |
| Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies (NCT07214688) | Hackensack Meridian Health | 2026-01-06 |
| Living Independence Through Functional Training (NCT07125378) | University of Florida | 2026-01-06 |
| Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine (NCT07400003) | Sinovac Biotech Co., Ltd | 2026-01-06 |
| Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) (NCT07160205) | Restem, LLC. | 2026-01-06 |
| Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease (NCT07378644) | Skyhawk Therapeutics, Inc. | 2026-01-06 |
| A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease (NCT07323732) | Memorial Sloan Kettering Cancer Center | 2026-01-06 |
| Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children (NCT07318831) | Tianjin Medical University Cancer Institute and Hospital | 2026-01-06 |
| Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma . (NCT07191249) | Tel-Aviv Sourasky Medical Center | 2026-01-05 |
| A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer (NCT07235618) | Sun Yat-sen University | 2026-01-05 |
| Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis (NCT07108387) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-01-05 |
| A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa (NCT07384975) | Navigator Medicines, Inc. | 2026-01-05 |
| Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining) (NCT07282834) | Patrick Wagner, MD, FACS | 2026-01-05 |
| Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line (NCT07501351) | Sun Yat-sen University | 2026-01-05 |
| RCT of Psilocybin-assisted CBT for Depression (NCT07281352) | University of California, Los Angeles | 2026-01-05 |
| Comparison Between Transarterial Musculoskeletal Embolization and Platelet-Rich Plasma Injection for the Treatment of Greater Trochanteric Pain Syndrome (NCT07396246) | Unidade Local de Saúde do Alto Ave, EPE | 2026-01-05 |
| A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation (NCT07219043) | Biogen | 2026-01-05 |
| A Clinical Trial of P134 Cells in Recurrent Glioblastoma (NCT07318818) | Tasly Pharmaceutical Group Co., Ltd | 2026-01-05 |
| Fasted vs. Fed State Exercise (NCT07487090) | Arkansas Colleges of Health Education | 2026-01-05 |
| Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus (NCT07363512) | Henan Cancer Hospital | 2026-01-05 |
| Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites (NCT07435701) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-01-05 |
| Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL (NCT07441993) | Institute of Hematology & Blood Diseases Hospital, China | 2026-01-05 |
| A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder (NCT07115329) | Syndeio Biosciences, Inc | 2026-01-05 |
| Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus (NCT06913023) | University Health Network, Toronto | 2026-01-05 |
| A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors (NCT07354711) | 3H Pharmaceuticals Co., Ltd. | 2026-01-04 |
| Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer. (NCT07339553) | Peking University Third Hospital | 2026-01-04 |
| Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer (NCT07457359) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-01-04 |
| Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma (NCT07511725) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-01-04 |
| Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures (NCT07208799) | Nishtar Medical University | 2026-01-03 |
| ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) (NCT07303699) | Obafemi Awolowo University Teaching Hospital | 2026-01-03 |
| Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children (NCT07320716) | GlaxoSmithKline | 2026-01-02 |
| A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion (NCT07063745) | Bristol-Myers Squibb | 2026-01-02 |
| Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage (NCT07294118) | The University of Texas Medical Branch, Galveston | 2026-01-02 |
| Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer (NCT07174570) | Emory University | 2026-01-02 |
| A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation (NCT07172919) | Amgen | 2026-01-02 |
| Topical Ketotifen 0.25% for Secondary Vestibulodynia (NCT07257029) | Center for Vulvovaginal Disorders | 2026-01-02 |
| Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma (NCT07282587) | Jazz Pharmaceuticals | 2026-01-02 |
| Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) (NCT07263139) | Agiana Pharmaceuticals | 2026-01-02 |
| Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease (NCT07300553) | Assistance Publique - Hôpitaux de Paris | 2026-01-02 |
| Efficacy of Interleukin-2 in Triple Negative Breast Cancer (NCT05821686) | Nova Scotia Health Authority | 2026-01-02 |
| Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML) (NCT07128381) | M.D. Anderson Cancer Center | 2026-01-02 |
| Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT07269639) | Seoul National University Hospital | 2026-01-01 |
| Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma (NCT07559045) | Second Affiliated Hospital of Zunyi Medical University | 2026-01-01 |
| Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation (NCT07214064) | University Hospital Tuebingen | 2026-01-01 |
| Preventing Early Childhood Caries With a Silver Diamine Fluoride Gel (NCT07455604) | The University of Hong Kong | 2026-01-01 |
| Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma (NCT07310173) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2026-01-01 |
| Children of Age 2-6years Undergoing Elective Surgery Will be Divided Into Two Groups Randomly. This Study Aims to Evaluate if Intranasal Dexmedetomidine is Better Than Intranasal Ketamine in Producing Sedation and Reducing Parent Separation Anxiety Before Surgery. (NCT07180095) | Liaquat National Hospital & Medical College | 2026-01-01 |
| A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT07354984) | Sun Yat-sen University | 2026-01-01 |
| Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM) (NCT07053033) | M.D. Anderson Cancer Center | 2026-01-01 |
| Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study (NCT07324473) | First Affiliated Hospital of Chongqing Medical University | 2026-01-01 |
| Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction (NCT07231185) | Aspargo Labs, Inc | 2026-01-01 |
| Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia (NCT07033598) | Theradex | 2026-01-01 |
| Improved Treatment and Monitoring of Alzheimer's Disease (NCT07135245) | Rune Skovgaard Rasmussen | 2026-01-01 |
| Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling (NCT06813274) | Hejiang Ye | 2026-01-01 |
| Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT) (NCT07312292) | Niek Wijnen | 2026-01-01 |
| Organoids for Bile Leaks (NCT07214649) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2026-01-01 |
| A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. (NCT07157033) | Xerient Pharma | 2026-01-01 |
| Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients (NCT04642287) | Massachusetts General Hospital | 2026-01-01 |